SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release.
about
Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase CExpression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells.Inflammation and cancer III. Somatostatin and the innate immune system.68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.Chronic bronchitis mimicking metastases from thyroid medullary carcinoma demonstrated by indium-111 pentetreotide scintigraphyCortistatin as a therapeutic target in inflammation.Treatment of Helicobacter gastritis with IL-4 requires somatostatin.Anti-inflammatory and immune therapy for Alzheimer's disease: current status and future directions.Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditionsOctreotide LAR: safety and tolerability issues.Successful treatment of protein-losing enteropathy due to AA amyloidosis with octreotide in a patient with rheumatoid arthritis.Signal transduction of somatostatin in human B lymphoblasts.Visualization of Gallbladder with In-111 Octreotide Scan.Effect of genetic SSTR4 ablation on inflammatory peptide and receptor expression in the non-inflamed and inflamed murine intestine.The somatostatin analog SOM230 (pasireotide) ameliorates injury of the intestinal mucosa and increases survival after total-body irradiation by inhibiting exocrine pancreatic secretion.Effects of somatostatin and octreotide on cytokine and chemokine production by lipopolysaccharide-activated peripheral blood mononuclear cells.Protein losing enteropathy in systemic lupus erythematosus: role of diet and octreotide.Somatostatin treatment attenuates proteinuria and prevents weight loss in NZB/W F1 mice.Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells.
P2860
Q24673814-A2227ADD-F69B-425B-89FC-8CE645010BE1Q34189365-C358770E-3B63-410F-9B60-51199BFB2AE9Q35739944-685CA751-88C0-4F48-B99C-DCFE0F1A6B09Q36275598-9F5CE7BE-3A42-4D19-A446-9E5D42333DB6Q36627186-6A240B9B-7ACE-4AEC-86AB-3BD06FA6273CQ36675481-8BBE1F65-D015-46FB-912C-DF80F3C009D7Q36689983-48C10298-C86C-45BF-BB33-6654C4E91677Q37101754-543406E5-B569-4500-A542-6721D196DB41Q37293161-D063BA8C-A84D-49A4-BD02-E9199C54C78FQ37340453-C06DDF49-06D2-4789-95AB-D1CA42B30A67Q37492012-B658CAC2-7F11-49E4-9FA9-0A95E7E5BE1DQ37649647-EAA1CCDB-89AD-4F93-ADE0-E9E78B87AE18Q38027786-C5709F3F-DF27-4B98-BA2C-833D4C1D13E0Q40696292-AF34D464-66B2-4F51-A80E-EE553422B00EQ42017761-C4D98159-877D-4F86-B3F5-DAB7D2D15154Q42186606-12293541-FB82-4F2C-B4A1-35417B097E93Q42553872-7986A603-4452-495F-BF15-A8FE8D6D1AC3Q43851375-5EC7E43A-8684-4A2D-9D40-A22B85C7C884Q44114238-8B0AB128-379D-49A9-A1CC-2361C554274BQ47323437-B432ED49-4A5B-43B7-9AB9-98DE7AC21F64Q52655396-3CC8D48F-626C-4947-9564-FBAD6C62CF8A
P2860
SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
SSTR2A is the dominant somatos ...... ates T cell IFN-gamma release.
@en
type
label
SSTR2A is the dominant somatos ...... ates T cell IFN-gamma release.
@en
prefLabel
SSTR2A is the dominant somatos ...... ates T cell IFN-gamma release.
@en
P2093
P2860
P1476
SSTR2A is the dominant somatos ...... ates T cell IFN-gamma release.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1521-4141(199908)29:08<2454::AID-IMMU2454>3.0.CO;2-H
P407
P577
1999-08-01T00:00:00Z